CBD showed selective cytotoxicity against three human cancer cell lines (cervical, breast, and colon) while leaving non-cancerous cells relatively unharmed.
Cancer researchers, CBD science enthusiasts, oncology-interested clinicians
CBD killed cancer cells at low micromolar doses while sparing normal cells
What the researchers found
CBD at 5-20 micromolar concentrations killed cancer cells through apoptosis with LC50 values of 9.4 (HeLa cervical), 10.3 (MDA-MB-231 breast), and 4.3 (CaCo-2 colon) micromolar at 24 hours. Non-cancerous cell lines (HaCaT skin, HUVEC endothelial) were relatively spared.
Why it matters
The selectivity of CBD for cancer cells over normal cells is a key finding. Many cancer treatments damage healthy tissue, so a compound that preferentially targets cancer cells has obvious therapeutic potential.
The numbers in context
LC50 at 24h: HeLa 9.4 micromolar, MDA-MB-231 10.3 micromolar, CaCo-2 4.3 micromolar. Tested at 5, 10, and 20 micromolar for 24, 48, 72, and 96 hours. Apoptosis confirmed by flow cytometry.
How the study worked
In vitro study treating three human cancer cell lines and two non-cancerous control lines with CBD at multiple concentrations (5, 10, 20 micromolar) across four time points (24-96 hours), using MTT assays, DAPI nuclear staining, and flow cytometry.
What this study cannot tell us
In vitro results often do not translate to living organisms. CBD concentrations tested may not be achievable in human tumors. No comparison with standard chemotherapy drugs. Cell line experiments are simplified models of complex cancers.
How to read the evidence
Well-designed in vitro study with appropriate controls, but cell line experiments are far from clinical relevance.
When this study was published
2025 in vitro study adding to the growing CBD-cancer research literature.
The bigger picture
CBD anti-cancer research is expanding rapidly. The selectivity seen here adds to growing evidence that cannabinoids interact differently with cancer versus normal cells, potentially through differences in cannabinoid receptor expression.
Questions still open
- Can these CBD concentrations be achieved in human tumors? Would CBD enhance conventional chemotherapy? What mechanisms explain the selectivity for cancer cells?
Common questions
Can CBD treat cancer?
Which cancers responded best to CBD in the lab?
Read the original research
Targeting Human Cancer Cells with Cannabidiol (CBD): Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines.
International journal of molecular sciences, 26(24)
Citation
Montes-de-Oca-Saucedo, Carlos R; Perales-Martínez, Jonathan E; Arellano-Barrientos, Juan C; Rodríguez-Tovar, Luis E; Nevárez-Garza, Alicia M; Garza-Arredondo, Aimé J; Saucedo-Cárdenas, Odila; Hernández-Vidal, Gustavo; Soto-Domínguez, Adolfo; Castillo-Velázquez, Uziel. (2025). Targeting Human Cancer Cells with Cannabidiol (CBD): Apoptotic Cytotoxicity in HeLa, MDA-MB-231, and CaCo-2 Lines.. International journal of molecular sciences, 26(24). https://doi.org/10.3390/ijms262412136
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk